Importantly, the presence of stromal CAFs and CD8(+) T cells is negatively and positively correlated with the survival of ovarian cancer patients, respectively, thus capitalizing the interaction between chemotherapy and immunotherapy holds significant potential to improve treatment outcomes of ovarian cancer patients (Wang et al., 2016). This evidence concerns the gene CD8A and ovarian cancer.